JP2005503762A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503762A5
JP2005503762A5 JP2002561074A JP2002561074A JP2005503762A5 JP 2005503762 A5 JP2005503762 A5 JP 2005503762A5 JP 2002561074 A JP2002561074 A JP 2002561074A JP 2002561074 A JP2002561074 A JP 2002561074A JP 2005503762 A5 JP2005503762 A5 JP 2005503762A5
Authority
JP
Japan
Prior art keywords
hybridization buffer
molecular weight
dextran sulfate
daltons
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002561074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503762A (ja
Filing date
Publication date
Priority claimed from US09/772,123 external-priority patent/US6656685B2/en
Application filed filed Critical
Publication of JP2005503762A publication Critical patent/JP2005503762A/ja
Publication of JP2005503762A5 publication Critical patent/JP2005503762A5/ja
Pending legal-status Critical Current

Links

JP2002561074A 2001-01-29 2002-01-29 低分子量デキストラン硫酸を使用するハイブリダイゼーション緩衝液およびそれらの使用方法 Pending JP2005503762A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/772,123 US6656685B2 (en) 2001-01-29 2001-01-29 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
PCT/US2002/002642 WO2002061139A2 (en) 2001-01-29 2002-01-29 Hybridization buffers using low molecular weight dextran sulfate and methods for their use

Publications (2)

Publication Number Publication Date
JP2005503762A JP2005503762A (ja) 2005-02-10
JP2005503762A5 true JP2005503762A5 (enExample) 2005-12-22

Family

ID=25093987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002561074A Pending JP2005503762A (ja) 2001-01-29 2002-01-29 低分子量デキストラン硫酸を使用するハイブリダイゼーション緩衝液およびそれらの使用方法

Country Status (8)

Country Link
US (2) US6656685B2 (enExample)
EP (1) EP1356116B1 (enExample)
JP (1) JP2005503762A (enExample)
AT (1) ATE361995T1 (enExample)
AU (1) AU2002240180B2 (enExample)
CA (1) CA2434854A1 (enExample)
DE (1) DE60220018T2 (enExample)
WO (1) WO2002061139A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2400448T3 (es) * 2001-04-30 2013-04-10 Ventana Medical Systems, Inc. Reactivos y métodos para la hibridación automatizada in situ o para microarray
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
DE102004028303A1 (de) * 2004-06-11 2005-12-29 Roche Diagnostics Gmbh Verfahren und Vorrichtung zum Nachweis von Analyten
WO2008018839A1 (en) * 2006-08-09 2008-02-14 National University Of Singapore Method for molecular biology applications
US7695929B2 (en) 2006-11-01 2010-04-13 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
ES2731432T3 (es) * 2007-05-23 2019-11-15 Ventana Med Syst Inc Transportadores poliméricos para inmunohistoquímica e hibridación in situ
EP2636757B1 (en) 2008-05-27 2016-11-23 Dako Denmark A/S Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
DK2995925T3 (da) 2008-06-05 2022-02-21 Ventana Med Syst Inc Sammensætning til histokemisk processering
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
WO2011057017A1 (en) * 2009-11-06 2011-05-12 Bend Research, Inc. Aqueous nanoparticle suspensions for use in drug discovery
SG192862A1 (en) 2011-03-11 2013-09-30 Univ Singapore Pericyte progenitors from peripheral blood
WO2013046033A1 (en) * 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
US11118226B2 (en) 2011-10-21 2021-09-14 Agilent Technologies, Inc. Hybridization compositions and methods
US10837879B2 (en) * 2011-11-02 2020-11-17 Complete Genomics, Inc. Treatment for stabilizing nucleic acid arrays
ES2753274T5 (es) * 2015-08-21 2023-05-26 42 Life Sciences Gmbh & Co Kg Composición y procedimiento de hibridación
EP3351263A1 (en) 2017-01-20 2018-07-25 Universitätsklinikum Hamburg-Eppendorf Pharmaceutical preparation for treating or preventing tissue adhesion
ES3008982T3 (en) 2017-08-18 2025-03-25 Neutrolis Inc Engineered dnase enzymes and use in therapy
CA3109238A1 (en) 2018-08-15 2020-02-20 Illumina, Inc. Compositions and methods for improving library enrichment
EP3864147A4 (en) 2018-10-08 2022-07-06 Neutrolis, Inc. MANIPULATION OF DNASE ENZYMES FOR MANUFACTURE AND THERAPY
US11058724B2 (en) 2018-10-08 2021-07-13 Neutrolis, Inc. Methods of using DNASE1-like 3 in therapy
US10988746B2 (en) 2018-10-08 2021-04-27 Neutrolis, Inc. Manufacturing and engineering of DNASE enzymes for therapy
US11352613B2 (en) 2019-02-04 2022-06-07 Neutrolis, Inc. Engineered human extracellular DNASE enzymes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4689294A (en) 1984-11-19 1987-08-25 Miles Laboratories, Inc. Enhancement of hybridization of nucleic acids by anionic polymers
US5985549A (en) 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US5447841A (en) * 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US4886741A (en) 1987-12-09 1989-12-12 Microprobe Corporation Use of volume exclusion agents for the enhancement of in situ hybridization
US5273905A (en) 1991-02-22 1993-12-28 Amoco Corporation Processing of slide mounted material
US5750340A (en) 1995-04-07 1998-05-12 University Of New Mexico In situ hybridization solution and process
US6127188A (en) * 1995-10-06 2000-10-03 Mj Research, Inc. Method and apparatus for controlling evaporation in histological procedures
US5763185A (en) * 1996-12-30 1998-06-09 Becton Dickinson And Company Method for reducing inhibitors of nucleic acid hybridization
ES2354598T3 (es) * 1998-02-27 2011-03-16 Ventana Medical Systems, Inc. Aparato de patología molecular automatizado que tiene calefactores de portaobjetos independientes.
US6855552B2 (en) * 1998-09-03 2005-02-15 Ventana Medical Systems Automated immunohistochemical and in situ hybridization assay formulations

Similar Documents

Publication Publication Date Title
JP2003519099A5 (enExample)
JP2005529870A5 (enExample)
EP2077283A4 (en) ETHYLENE COPOLYMER, COPOLYMER COMPOSITION, AND METHOD OF MANUFACTURE
EP2517691A3 (en) Abrasive system for oral care compositions
JP2006502129A5 (enExample)
EP2039804A3 (en) Use of quaternary ammonium carbonates and bicarbonates in anticorrosive coatings of metal substrates
JP2003517386A5 (enExample)
ATE442806T1 (de) Geschirrkorb einer geschirrspülmaschine
JP2007051233A5 (enExample)
EP1510168A3 (en) Wash arm arrangement for a dishwasher
JPH09235233A5 (enExample)
EP1613585A4 (en) COMPOUNDS AND METHOD FOR USE IN THE TREATMENT OF NEOPLASMS AND CANCER BASED ON INHIBITORS OF ISOPRENYLCYSTEIN METHYLTRANSFERASE
JP2008506698A5 (enExample)
JP2006008520A5 (enExample)
EP2322559A3 (en) Neoplasm specific antibodies and uses thereof
JPH116484A5 (enExample)
JP2004100059A5 (enExample)
JP2008505206A5 (enExample)
FR2888114B1 (fr) Utilisation cosmetique du madecassoside et/ou du terminoloside comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
JP2005154579A5 (enExample)
RU2001113347A (ru) Буферная жидкость
RU2003131603A (ru) Сорбционный материал с бактерицидными свойствами на основе оксида алюминия
RU2002130238A (ru) Средство, нормализующее обмен веществ в тканях кожи
CN208789614U (zh) 一种防水型汽车后窗台装饰板
Monroe Light and human health.